BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7315152)

  • 1. [Follow-up of patients with pituitary tumors before and after operation, medical treatment and radiotherapy (author's transl)].
    Gasser RW; Finkenstedt G; Skrabal F
    Acta Med Austriaca; 1981; 8(4):112-20. PubMed ID: 7315152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional antitumoral effects of bromocriptine and radiotherapy in patients with prolactinomas or acromegaly.
    Coculescu M; Alessandrescu D; Stoica T; Simionescu N; Dimitriu V; Oprescu M; Chelmu S; Urba-Navicius V; Isbăşoiu O
    Endocrinologie; 1980; 18(4):277-88. PubMed ID: 7209360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hormonal effects of pituitary surgery and irradiation: a review of 59 cases.
    Wittert G; Donald RA; Espiner EA; Livesey JH; Fox H
    N Z Med J; 1985 Feb; 98(773):93-7. PubMed ID: 2983273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endoscopic intrasellar tumor surgery].
    Zhang Q; Ni Z; Sun H; Zhang J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Oct; 37(5):363-5. PubMed ID: 12772458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of pituitary adenomas].
    Mezosi E; Nemes O
    Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of pituitary tumors.
    Post KD; Muraszko K
    Neurol Clin; 1986 Nov; 4(4):801-31. PubMed ID: 3540586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
    Coculescu M; Simionescu N; Oprescu M; Alessandrescu D
    Endocrinologie; 1983; 21(3):157-68. PubMed ID: 6635518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Craniopharyngioma: a personal (Boston) experience.
    Scott RM
    Childs Nerv Syst; 2005 Aug; 21(8-9):773-7. PubMed ID: 15965668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra- and postoperative plasma ACTH concentrations in patients with Cushing's disease cured by transsphenoidal pituitary surgery.
    Czirják S; Bezzegh A; Gál A; Rácz K
    Acta Neurochir (Wien); 2002 Oct; 144(10):971-7; discussion 977. PubMed ID: 12382124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug and radiotherapy of pituitary tumors].
    Yoshida H; Takeda F; Kinouchi T; Shimizu N
    Nihon Rinsho; 1986 Mar; 44(3):659-66. PubMed ID: 3016373
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bromocriptine treatment of invasive giant prolactinomas prior to comprehensive treatments: results of a long-term follow up].
    Zhang HW; Yu CJ; Sun W; Yang J; Yan CX; Cun EH
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(22):1555-7. PubMed ID: 17359664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric pituitary adenoma: a series of 42 patients.
    Pandey P; Ojha BK; Mahapatra AK
    J Clin Neurosci; 2005 Feb; 12(2):124-7. PubMed ID: 15749410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transsphenoidal resection of pituitary adenomas: long-term results from the Leiden University Medical Center].
    Biermasz NR; Dekkers OM; Voormolen J; de Keizer RJ; Neelis KJ; Wiggers-de Bruïne FT; Smit JW; Arias AM; Romijn JA
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2565-70. PubMed ID: 19174939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
    Santoro A; Minniti G; Ruggeri A; Esposito V; Jaffrain-Rea ML; Delfini R
    Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent advances in post-therapeutic hormonal surveillance of prolactin adenomas (author's transl)].
    Turpin G; Heshmati HM; Zygelman N; Van Effenterre R; Gaham N; De Gennes JL
    Ann Med Interne (Paris); 1982; 133(1):35-7. PubMed ID: 7065587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A; Sanno N; Tahara S; Osamura YR
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histological changes and operative findings of pituitary adenomas after bromocriptine treatment].
    Takahashi T; Kuwayama A; Katoh T; Kageyama N
    Nihon Naibunpi Gakkai Zasshi; 1986 Dec; 62(12):1336-51. PubMed ID: 3817228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients.
    Esposito V; Santoro A; Minniti G; Salvati M; Innocenzi G; Lanzetta G; Cantore G
    Neurol Sci; 2004 Dec; 25(5):251-6. PubMed ID: 15624082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.